Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

V.M. Legrand; P.W. Serruys; F. Unger; B.A. van Hout; MC Vrolix; GM Fransen; TT Nielsen; PK Paulsen; R.S. Gomes; JM de Queiroz e Melo; JP Neves; W. Lindeboom; B Backx

Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

Translated title of the contribution: Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

V.M. Legrand, P.W. Serruys, F. Unger, B.A. van Hout, MC Vrolix, GM Fransen, TT Nielsen, PK Paulsen, R.S. Gomes, JM de Queiroz e Melo, JP Neves, W. Lindeboom, B Backx

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

BACKGROUND: The primary results of Arterial Revascularization Therapy Study reported a greater need for repeated revascularization after percutaneous coronary intervention with stenting (PCI). However, PCI was less expensive than coronary artery bypass grafting (CABG) and offered the same degree of protection against death, stroke, and myocardial infarction. METHODS AND RESULTS: Patients with multivessel disease (n=1205) were randomly assigned to either CABG or PCI and followed up for up to 3 years. Survival rates without stroke or myocardial infarction were similar in each group at 1 year and 3 years (90.5% versus 91.4% for PCI versus CABG at 1 year and 87.2% versus 88.4% for PCI versus CABG at 3 years). However, the respective repeat revascularization rates were 21.2% and 26.7% at 1 and 3 years in patients allocated to PCI, compared with 3.8% and 6.6% in patients allocated to CABG (P

Translated title of the contribution	Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.
Original language	Undefined/Unknown
Pages (from-to)	1114-20
Number of pages	7
Journal	Circulation
Volume	109
Issue number	9
Publication status	Published - 2004

Cite this

@article{92805fbc0cd34a728d74ee249612b12a,

title = "Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.",

abstract = "BACKGROUND: The primary results of Arterial Revascularization Therapy Study reported a greater need for repeated revascularization after percutaneous coronary intervention with stenting (PCI). However, PCI was less expensive than coronary artery bypass grafting (CABG) and offered the same degree of protection against death, stroke, and myocardial infarction. METHODS AND RESULTS: Patients with multivessel disease (n=1205) were randomly assigned to either CABG or PCI and followed up for up to 3 years. Survival rates without stroke or myocardial infarction were similar in each group at 1 year and 3 years (90.5% versus 91.4% for PCI versus CABG at 1 year and 87.2% versus 88.4% for PCI versus CABG at 3 years). However, the respective repeat revascularization rates were 21.2% and 26.7% at 1 and 3 years in patients allocated to PCI, compared with 3.8% and 6.6% in patients allocated to CABG (P",

author = "V.M. Legrand and P.W. Serruys and F. Unger and {van Hout}, B.A. and MC Vrolix and GM Fransen and TT Nielsen and PK Paulsen and R.S. Gomes and {de Queiroz e Melo}, JM and JP Neves and W. Lindeboom and B Backx",

year = "2004",

language = "Undefined/Unknown",

volume = "109",

pages = "1114--20",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "9",

}

TY - JOUR

T1 - Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

AU - Legrand, V.M.

AU - Serruys, P.W.

AU - Unger, F.

AU - van Hout, B.A.

AU - Vrolix, MC

AU - Fransen, GM

AU - Nielsen, TT

AU - Paulsen, PK

AU - Gomes, R.S.

AU - de Queiroz e Melo, JM

AU - Neves, JP

AU - Lindeboom, W.

AU - Backx, B

PY - 2004

Y1 - 2004

N2 - BACKGROUND: The primary results of Arterial Revascularization Therapy Study reported a greater need for repeated revascularization after percutaneous coronary intervention with stenting (PCI). However, PCI was less expensive than coronary artery bypass grafting (CABG) and offered the same degree of protection against death, stroke, and myocardial infarction. METHODS AND RESULTS: Patients with multivessel disease (n=1205) were randomly assigned to either CABG or PCI and followed up for up to 3 years. Survival rates without stroke or myocardial infarction were similar in each group at 1 year and 3 years (90.5% versus 91.4% for PCI versus CABG at 1 year and 87.2% versus 88.4% for PCI versus CABG at 3 years). However, the respective repeat revascularization rates were 21.2% and 26.7% at 1 and 3 years in patients allocated to PCI, compared with 3.8% and 6.6% in patients allocated to CABG (P

AB - BACKGROUND: The primary results of Arterial Revascularization Therapy Study reported a greater need for repeated revascularization after percutaneous coronary intervention with stenting (PCI). However, PCI was less expensive than coronary artery bypass grafting (CABG) and offered the same degree of protection against death, stroke, and myocardial infarction. METHODS AND RESULTS: Patients with multivessel disease (n=1205) were randomly assigned to either CABG or PCI and followed up for up to 3 years. Survival rates without stroke or myocardial infarction were similar in each group at 1 year and 3 years (90.5% versus 91.4% for PCI versus CABG at 1 year and 87.2% versus 88.4% for PCI versus CABG at 3 years). However, the respective repeat revascularization rates were 21.2% and 26.7% at 1 and 3 years in patients allocated to PCI, compared with 3.8% and 6.6% in patients allocated to CABG (P

M3 - Article

SN - 0009-7322

VL - 109

SP - 1114

EP - 1120

JO - Circulation

JF - Circulation

IS - 9

ER -

Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

Abstract

Fingerprint

Cite this